Purchases and Sales Made in Q2 2021 in Aeglea Bio Therapeutics, Inc. (AGLE)
This table provides information about the institutional ownership of Aeglea Bio Therapeutics, Inc. (AGLE) during Q2 2021. The information is specifically focused on institutions that hold shares of Aeglea BioTherapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 13, 2021
Q2 2021
|
Algert Global LLC
San Francisco, CA |
SELL
|
- |
-25.3K- 37.89% |
$160K - $212K
|
41.5K
$1.15M
|
|
|
Aug 13, 2021
Q2 2021
|
Barclays PLC
London, X0 |
SELL
|
- |
-32.3K- 85.07% |
$204K - $271K
|
5.67K
$157K
|
|
|
Aug 16, 2021
Q2 2021
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-33.8KClosed |
$214K - $283K
|
0
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Nantahala Capital Management, LLC
New Canaan, CT |
SELL
|
- |
-35.1K- 2.05% |
$222K - $294K
|
1.68M
$46.4M
|
|
|
Aug 12, 2021
Q2 2021
|
State Of Wisconsin Investment Board
Madison, WI |
SELL
|
- |
-60.3KClosed |
$381K - $505K
|
0
$0
|
|
|
Aug 04, 2021
Q2 2021
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-60.4K- 71.55% |
$382K - $507K
|
24K
$665K
|
|
|
Aug 13, 2021
Q2 2021
|
California Public Employees Retirement System
Sacramento, CA |
SELL
|
- |
-64.5K- 75.57% |
$407K - $540K
|
20.8K
$576K
|
|
|
Aug 13, 2021
Q2 2021
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-83K- 18.39% |
$524K - $695K
|
368K
$10.2M
|
|
|
Aug 16, 2021
Q2 2021
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-130K- 68.7% |
$822K - $1.09M
|
59.3K
$1.64M
|
|
|
Aug 16, 2021
Q2 2021
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-175KClosed |
$1.11M - $1.47M
|
0
$0
|
|
|
Aug 13, 2021
Q2 2021
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-540K- 45.32% |
$3.41M - $4.52M
|
651K
$18M
|
|
|
Aug 16, 2021
Q2 2021
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-1.03M- 68.68% |
$6.51M - $8.63M
|
470K
$13M
|